MPN Clinical Trials

Ongoing MPN Trials @ NCIS - Patient Recruitment


Protocol Title and Number Patient Selection Criteria Principal Investigator

A phase Ib, multi-centre, open label, dose escalation study of PIM447 in combination with ruxolitinib (INC424) and LEE011 administered orally in patients with myelofibrosis. (DSRB reference: 2014/01293)

- You must be diagnosed with JAK2V617F positive primary/ secondary MF

- You must have an enlarged spleen

- You must have adequate bone marrow function

 

 

Dr Ng Chin Hin

 

 

 

MPN Experimental Assessment of Symptoms by Utilising Repetitive Evaluation (MEASURE) Trial. (DSRB reference: 2015/00252)

 

- You must be diagnosed with ET, PV, Primary MF or post-ET/post-PV MF

- You will be required to fill out a symptom diary for 7 days prior to starting any therapy and for another 7 days after starting treatment


 

 

Dr Tung Moon Ley 

 

 

Proteomic analysis of platelets in patients with Essential Thrombocythaemia. (DSRB reference: 2016/01095)

 

You must be diagnosed with Essential Thrombocythaemia


Dr Tung Moon Ley / Dr Christina Yip Yew Ching

 

 Updated as of 16 January 2017


Contact Us

Are you interested to participate in a clinical trial?

 

To find out if you are eligible for a particular clinical trial, talk to your doctor at our Cancer Centre today.


For more information please contact:

 

Ms Vilianty
Clinical Research Administrator
DID : +65 6772 4619
Email: vilianty@nuhs.edu.sg 

 

Miss Joan Phee
Research Administrator
DID : +65 6772 2404
Email: joan_phee@nuhs.edu.sg